Sanofi-Aventis
11 products tracked · names used in filings: Sanofi-Aventis, Sanofi Aventis, sanofi-aventis, Sanofi-aventis Deutschland GmbH, sanofi-aventis Deutschland GmbH
Upcoming milestones
No upcoming milestones listed.
Recent milestones
No recent milestones.
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Sliwens | Application withdrawn | |
| 🇪🇺 | Multaq dronedarone | Application withdrawn | |
| 🇪🇺 | Aquilda satavaptan | Application withdrawn | |
| 🇪🇺 | Insulin Human Winthrop insulin human | Withdrawn | 2007-01-17 |
| 🇪🇺 | Zimulti rimonabant | Withdrawn | 2006-06-19 |
| 🇪🇺 | Acomplia rimonabant | Withdrawn | 2006-06-19 |
| 🇪🇺 | Apidra insulin glulisine | Authorised | 2004-09-27 |
| 🇪🇺 | Toujeo (previously Optisulin) insulin glargine | Authorised | 2000-06-26 |
| 🇪🇺 | Lantus insulin glargine | Authorised | 2000-06-09 |
| 🇪🇺 | Arava leflunomide | Authorised | 1999-09-02 |
| 🇪🇺 | Insuman insulin human | Authorised | 1997-02-21 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.